In a few SFN-treated prostate cancer cell lines, several class I and class II HDAC (HDAC3, HDAC4, HDAC6, and HDAC8) protein levels decreased, whereas in normal cells, only a temporary depletion of HDAC activity was noticed. This evidence concerns the gene HDAC9 and Familial prostate cancer.